Literature DB >> 31768846

New Positive Allosteric Modulator of AMPA Receptors: in vitro and in vivo Studies.

V V Grigoriev1, M I Lavrov1,2, V L Zamoyski3, T L Garibova4, V A Palyulin1,2, S O Bachurin1.   

Abstract

A new derivative of 3,7-diazabicyclo[3.3.1]nonane, which showed a high activity as a positive allosteric modulator of AMPA receptors of the CNS, was studied in electrophysiological experiments. At doses of 0.01 mg/kg, this compound significantly improved the memory of experimental animals disturbed by maximal electric shock. The results indicate that this compound is a promising candidate for preclinical trials and clinical studies as a drug for treatment of a number of psychoneurological diseases.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31768846     DOI: 10.1134/S160767291905003X

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN: 1607-6729            Impact factor:   0.788


  7 in total

1.  Novel 1,2,4-thiadiazole derivatives as potent neuroprotectors: approach to creation of bioavailable drugs.

Authors:  German L Perlovich; Alexey N Proshin; Tatyana V Volkova; Ludmila N Petrova; Sergey O Bachurin
Journal:  Mol Pharm       Date:  2012-03-06       Impact factor: 4.939

Review 2.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

3.  A translational approach to evaluate the efficacy and safety of the novel AMPA receptor positive allosteric modulator org 26576 in adult attention-deficit/hyperactivity disorder.

Authors:  Lenard A Adler; René A Kroon; Mark Stein; Mohammed Shahid; Frank I Tarazi; Armin Szegedi; Jacques Schipper; Pilar Cazorla
Journal:  Biol Psychiatry       Date:  2012-07-06       Impact factor: 13.382

4.  Novel bivalent positive allosteric modulators of AMPA receptor.

Authors:  M I Lavrov; V V Grigor'ev; S O Bachurin; V A Palyulin; N S Zefirov
Journal:  Dokl Biochem Biophys       Date:  2015-10-31       Impact factor: 0.788

Review 5.  Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends.

Authors:  Sergey O Bachurin; Elena V Bovina; Aleksey A Ustyugov
Journal:  Med Res Rev       Date:  2017-01-13       Impact factor: 12.944

6.  AMPA receptor positive allosteric modulators attenuate morphine tolerance and dependence.

Authors:  Xiaoyu Hu; Xuebi Tian; Xiao Guo; Ying He; Haijun Chen; Jia Zhou; Zaijie Jim Wang
Journal:  Neuropharmacology       Date:  2018-04-25       Impact factor: 5.250

7.  Chronic Ampakine Treatments Stimulate Dendritic Growth and Promote Learning in Middle-Aged Rats.

Authors:  Julie C Lauterborn; Linda C Palmer; Yousheng Jia; Danielle T Pham; Bowen Hou; Weisheng Wang; Brian H Trieu; Conor D Cox; Svetlana Kantorovich; Christine M Gall; Gary Lynch
Journal:  J Neurosci       Date:  2016-02-03       Impact factor: 6.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.